Elizabeth Olek

Elizabeth Olek

Technik-/Wissenschafts-/F&E-Leiter bei KRONOS BIO, INC.
61 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Elizabeth A. Olek currently works at Kronos Bio, Inc., as Senior Vice President-Clinical Development.
Dr. Olek also formerly worked at Genetics Institute LLC, as Director-Clinical Research from 1998 to 2002, InterMune, Inc., as Director-Clinical Research from 2003 to 2004, Novartis Pharmaceuticals Corp., as Global Brand Medical Director from 2005 to 2007, Wyeth Research, as Director-Clinical Research from 1998 to 2002, Loxo Oncology, Inc., as Executive Director-Clinical Research from 2019 to 2022, and Achillion Pharmaceuticals, Inc., as Chief Medical Officer & SVP-Clinical Development from 2011 to 2012.
Dr. Olek received her graduate degree from Boston University, undergraduate degree from the University of the Sciences in Philadelphia, and doctorate degree from Philadelphia College of Osteopathic Medicine.

Aktive Positionen von Elizabeth Olek

UnternehmenPositionBeginn
KRONOS BIO, INC. Technik-/Wissenschafts-/F&E-Leiter -

Ehemalige bekannte Positionen von Elizabeth Olek

UnternehmenPositionEnde
LOXO ONCOLOGY INC Corporate Officer/Principal 01.02.2022
ACHILLION PHARMACEUTICALS, INC. Technik-/Wissenschafts-/F&E-Leiter 18.06.2012
Corporate Officer/Principal 01.11.2007
INTERMUNE INC Technik-/Wissenschafts-/F&E-Leiter 01.07.2004
Technik-/Wissenschafts-/F&E-Leiter 01.12.2002
Sehen Sie sich die Erfahrung von Elizabeth Olek im Detail an

Ausbildung von Elizabeth Olek

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

60

Beziehungen ersten Grades

10

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen10

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Elizabeth Olek